GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a substantial shift in how we handle type 2 diabetes . These new medications help stimulating the body’s own GLP-1 process, which https://bookmark-rss.com/story21567162/glp-1-a-significant-advance-in-blood-sugar-management